Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farha Naz

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|July 17, 2020
Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?Farha Naz, Mohd Arish
Current Research in Immunology|June 9, 2022
Sphingosine-1-phosphate receptors 2 and 3 reprogram resting human macrophages into M1 phenotype following mycobacteria infectionMohd Arish, Farha Naz
European Journal of Immunology|March 20, 2022
Macrophage plasticity as a therapeutic target in tuberculosisMohd Arish, Farha Naz
Frontiers in Pharmacology|February 26, 2026
Sphingosine-1-phosphate receptor signaling regulates an ERK1/2-p65 molecular switch in macrophages during <i>Leishmania donovani</i> infectionMohd Arish, Farha Naz
British Journal of Pharmacology|November 5, 2020
GPCRs as an emerging host-directed therapeutic target against mycobacterial infection: From notion to realityFarha Naz, Mohd Arish
Personalized Medicine|October 15, 2021
Personalized therapy: can it tame the COVID-19 monster?Mohd Arish, Farha Naz
Clinical Microbiology Reviews|May 10, 2023
Host Immunity and Immunization Strategies for Clostridioides difficile InfectionFarha Naz, William A Petri
Frontiers in Immunology|March 29, 2024
Editorial: Sphingolipids in infections, diseases, and disordersFarha Naz, Mohd Arish, Imtaiyaz Hassan
Frontiers in Immunology|September 2, 2025
Editorial: Unveiling the host's acute immune response to infectious mucosal diseases: insights and implicationsMohd Arish, Carmen Fernández, Farha Naz
Frontiers in Immunology|September 22, 2025
Editorial: Mucosal immunity after vaccinationMohd Arish, Mireia López-Siles, Farha Naz
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|July 17, 2020
Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?Farha Naz, Mohd Arish
Current Research in Immunology|June 9, 2022
Sphingosine-1-phosphate receptors 2 and 3 reprogram resting human macrophages into M1 phenotype following mycobacteria infectionMohd Arish, Farha Naz
European Journal of Immunology|March 20, 2022
Macrophage plasticity as a therapeutic target in tuberculosisMohd Arish, Farha Naz
Frontiers in Pharmacology|February 26, 2026
Sphingosine-1-phosphate receptor signaling regulates an ERK1/2-p65 molecular switch in macrophages during <i>Leishmania donovani</i> infectionMohd Arish, Farha Naz
British Journal of Pharmacology|November 5, 2020
GPCRs as an emerging host-directed therapeutic target against mycobacterial infection: From notion to realityFarha Naz, Mohd Arish
Personalized Medicine|October 15, 2021
Personalized therapy: can it tame the COVID-19 monster?Mohd Arish, Farha Naz
Clinical Microbiology Reviews|May 10, 2023
Host Immunity and Immunization Strategies for Clostridioides difficile InfectionFarha Naz, William A Petri
Frontiers in Immunology|March 29, 2024
Editorial: Sphingolipids in infections, diseases, and disordersFarha Naz, Mohd Arish, Imtaiyaz Hassan
Frontiers in Immunology|September 2, 2025
Editorial: Unveiling the host's acute immune response to infectious mucosal diseases: insights and implicationsMohd Arish, Carmen Fernández, Farha Naz
Frontiers in Immunology|September 22, 2025
Editorial: Mucosal immunity after vaccinationMohd Arish, Mireia López-Siles, Farha Naz
Pageof 4